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ABSTRACT
Objective: Coronavirus disease 2019 (COVID-19) infection evolved as a worst nightmare across entire humanity especially for health care workers along 
with all stakeholders of the society ever since the beginning of year 2020. Vaccination campaign is one of the most successful public health interventions 
and a cornerstone for the prevention of communicable infectious diseases. To have a baseline data and to form the basis for further vaccination drive, we 
carried out this study with an objective to understand the perception and COVID-19 vaccine hesitancy among health care workers (HCWs).
Methods: A correctional study was carried out at one of the multispecialty hospital in North India where COVID-19 vaccination for HCWs was planned 
and 675 HCWs were taken into the study. Data were collected by means of personal interview using pretested semi-structured questionnaire and Epi 
Info version 6 was used for analysis.
Results: The mean age of the participants was 32.78 years. Majority were male (89.48%), working in government sector (87.7%) and paramedic 
(88.15%). While 94.67% were accepting vaccine voluntarily while remaining were not confident enough on their own, only 26.96% were ready to take 
vaccine even on payment. The overall awareness scores of study participants were calculated and found that 79.56% of them had poor awareness level 
while only 20.44% had satisfactory awareness level. The association of awareness score was statistically significant with job profile (designation), 
gender, and prior COVID-19 positivity of study participants.
Conclusion: The decision of vaccine prioritization to HCWs and frontline workers will boost the morale and spirit of warriors high in future. This 
study was a preliminary attempt to check any vaccine hesitancy factors among HCWs and act accordingly. Although almost all had volunteered for 
vaccine, the knowledge about vaccine was poor in majority of HCWs as the time period was recent to vaccine rollout and detailed research findings 
were not yet out about vaccine. All measures to be taken including intensive information education and communications activities targeting HCWs 
and general population on regular basis to upgrade the knowledge on vaccine issues. A strong communicating policy in an era of misinformation is 
highly recommended as social media plays an important role in spreading true as well as false messages jeopardizing the entire gains of successful 
vaccination and attainment of herd immunity. Heath Care Workers to act as role model for general public and patients, which would in turn increase 
the vaccine acceptance.
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INTRODUCTION
Coronavirus disease 2019 (COVID-19) is super-infectious disease 
caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2). COVID-19 infection evolved as a worst nightmare across entire 
humanity especially for health care workers (HCWs) along with all 
stakeholders of the society ever since the beginning of year 2020, when 
the World Health Organization (WHO) declared it as pandemic with 
rising infection rate and severity across the world. This virus caused 
respiratory illness ranging from the common cold to severe disease. It 
caused illness across all age group but severely affected older people 
and those with underlying medical problems such as cardiovascular 
disease, diabetes, chronic respiratory disease, and cancer [1]. It was 
first identified in Wuhan, China, in December 2019 and is an on-going 
pandemic. In India, the first case reported in Kerala state in January 
2020, being novel virus there was no specific treatment and vaccine till 
end of year 2020.
The control of COVID-19 is a huge challenge due to fear of unknown, 
India was quick to close its international borders and enforce an 
immediate lockdown [2] for emergency preparedness and response. As 
of December 27, 2020, there have been over 79.2 million cases and over 
1.7 million deaths reported globally since the start of the pandemic, 
whereas in India, alone total cumulative cases were over 10,187,850 
and 147,622 deaths reported [3]. There is significant reduction of 
HCWs capacity through periods of infection by quarantine, isolation 
guidelines, and round the clock hectic work schedule under stress.
After various public health measures such as nation-wide lockdown, 
containment zones, isolation centers, quarantine centers to simple 
social distancing, masking, and hand washing, the world was eagerly 
waiting for vaccination campaign which is one of the most successful 
public health interventions and a cornerstone for the prevention of 
communicable infectious diseases. Notwithstanding vaccine progress, 
ongoing public acceptance is required to maintain herd immunity, 
prevent outbreaks of vaccine preventable illnesses, and ensure 
adoption of novel vaccines [2]. Any new vaccine introduction in short 
period of span creates lots of doubts and hesitancy among both HCWs 
and general public as we have seen in H1N1 infection too [4]. Vaccine 
hesitancy refers to delay in acceptance or refusal of vaccination despite 
availability of vaccination services. Vaccine hesitancy is complex and 
context specific, varying across time, place, and vaccines. It is influenced 
by factors such as complacency, convenience, and confidence [5]. Vaccine 
hesitancy will create isolation from vaccination for any individual when 
they triggered by variety of unknown sources of information either 
through social media or message sharing messengers without health 
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editorial oversight [6], which is extreme potential threat to public 
health interventional strategies. The simple forward of message leads 
full throated castigation which compromises the vaccine development 
for novel viruses.
At one side, HCWs are strongest influencers in vaccination decisions 
as common population and patients show greater resistance to accept 
novel vaccines [7], on the other side, COVID-19 pandemic has reminded 
all of us of the vital role health workers played to relieve suffering and 
save lives. Thus, recognizing health worker safety as a priority for 
patient safety, WHO Member States, and all relevant stakeholders urged 
to take urgent and sustainable action and in the context of emergency 
response, giving health workers priority access to newly licensed and 
available vaccines [8].
The union Health Ministry of India advised all states to commence 
COVID-19 vaccination drive to HCWs on January 16, 2021, as priority 
one and approved two vaccines for restricted emergency use in India [9]. 
The massive Phase 1 vaccination drive carried out with “Covishield 
manufactures by Serum Institute of India” and indigenously developed 
“Covaxine” of Bharat Biotech which has been offered two doses for free 
of cost to all HCWs and frontline workers (FLWs).
In view of above, to have a baseline data and to form the basis for further 
vaccination drive, we carried out this study with an aim to understand 
the perception and COVID-19 vaccine hesitancy among HCWs. At our 
study area, Covishield vaccine was provided by Government of India 
to all HCWs. COVISHIELD is ChAdOx1-S/nCoV-19 (recombinant) 
vaccine which again is a recombinant vaccine with replication deficient 
chimpanzee adenovirus vector encoding the SARS-COV-2 spike 
glycoprotein. The vaccine is genetically modified in human embryonic 
kidney 293 cells [10].
METHODS
A correctional study was carried out at one of the multispecialty hospital 
in North India where COVID-19 vaccination for HCWs was planned. 
COVID-19 vaccination was planned for approximately 1010 HCWs with 
target of 100–150 per day. About 95% of vaccination was achieved in 
10 days. On each day before inoculation, pre-tested semi-structured 
questionnaire was used to gather information about awareness and 
vaccine acceptance/hesitancy among HCWs and data were collected by 
means of personal interview.
Expecting the vaccine acceptance and awareness rate of 50%, alpha 
5%, and chance error 5%, the sample size calculated was 385. However, 
since 675 HCWs were willing for the study and gave consent, 675 
HCWs were taken into the study. All those who refused for consent and 
unwilling were excluded from study. Data collected were entered into 
Excel sheet and Epi Info version 6 was used for analysis. Chi-square was 
used for proportions comparison at statistical significance at p<0.05%. 
To assess collective awareness, set of 12 questions was selected. One 
mark for given for right answer and zero mark for wrong. Total scores 
were divided into two categories, poor awareness (<50% marks) and 
satisfactory awareness (more than 50% marks).
RESULTS
The mean age of the participants was 32.78 years. Majority were male 
(89.48%), working in government sector (87.7%) and paramedic 
(88.15%) (Table 1). About 41 (6.07%) of the participants have suffered 
with COVID-19 earlier with 2 (0.30%) of them suffered 6 months ago 
and 39 (5.78%) of them suffered 3 months ago. Thirty-two (4.74%) 
of them had symptoms related to COVID-19 but not tested while one 
had their family member with COVID-19-related symptoms earlier. 
All of them 675 (100%) knew about two variety of vaccines but only 
130 (19.26%) knew about the correct type of vaccine available at their 
center before being administration, implying that irrespective of type 






Fig. 1: Awareness level among study participants
About 100% knew about two variety of vaccines launched by 
government and 19.26% knew about the type of vaccines allotted to 
HCWs at their center. When asked about benefits of taking COVID-19 
vaccine, 100% said that it will protect us from COVID-19 infection 
while 64.59% of them said that it protects family members too. About 
74.67% said that both vaccines are equally effective while 19.26% said 
that Covisheild is better than Covaxine. When asked about reasons for 
thinking the vaccine is best, 27.70% told it’s because of lesser side 
effects, easy availability (4.74%), and good efficacy (9.93%) (Table 2). 
Majority (62.67%) did not know about when immunity is achieved 
after taking vaccine while 23.85% told that they will be immune 
within 1–2 weeks. Surprisingly, 31.26% told that vaccine is effective 
against mutant strains while 36.30% did not know anything about it. 
Majority of them rightly knew about side effects which included pain 
(96.15%), fever (65.48%), allergic reactions (48.04%), and paralysis 
(8.15%). Even at this point when cases and deaths are declining in 
this country, 49.19% HCWs agreed that vaccine is required and 26% 
felt that vaccine is required even for those who contracted COVID-19 
disease earlier.
While 94.67% were accepting vaccine voluntarily while remaining 
were not confident enough on their own, only 26.96% were ready to 
take vaccine even on payment (Table 3).
The overall awareness scores of study participants were calculated 
and found that 79.56% of them had poor awareness level while only 
20.44% had satisfactory awareness level (Fig. 1). The association 
of awareness score was statistically significant with job profile 
(designation), gender, and prior COVID-19 positivity of study 
participants (Table 5).





<25 years 148 21.93
25–35 years 309 45.78
35–45 years 151 22.37





Medical officer 38 5.63
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Table 2: Awareness regarding available COVID-19 vaccine in 
India
Variables Frequency (n=675) Percent




Reasons for thinking this vaccine is best
Do not know 389 57.63
Easily available 32 4.74
Good efficacy 67 9.93
Less side effects 187 27.70
After getting vaccine, immunity is achieved 
After 3–5 weeks 46 6.81
After 6–8 weeks 20 2.96
After 8 weeks 25 3.70
Do not know 423 62.67
Within 1–2 weeks 161 23.85
Does vaccine effective against mutant strains






Allergic reaction 332 48.04
Fever 442 65.48
Others – –
COVID-19: Coronavirus disease 2019
DISCUSSION
Ever since the COVID-19 pandemic, countries across the world were 
trying hard for an effective vaccine. Finally, vaccines of Moderna, Pfizer 
BioNtech, and Oxford Astrazeneca were recently approved [11]. India 
also approved two vaccines on January 3, 2021, for restricted use under 
emergency [9] and finally vaccination drive for high-risk individuals 
was started on January 16, 2021, for HCWs. This study was carried out 
between January 16, 2021, and January 30, 2021, among HCWs at the 
COVID-19 vaccination center before getting vaccinated. Our study was 
an effort to see the perceptions of HCWs about vaccine acceptance/
hesitancy as acceptance by HCWs would influence drastically the 
vaccine acceptance by general population and would act as a role model 
to others.
In our study, 100% of participants said that they would continue 
practices of COVID-19 precautionary measures, even after vaccination 
also, which was very appreciable. About 80.44% of participants 
strongly believed that beneficiaries could spread infection and can get 
infected (73.93%) even after vaccination. When majority believed that 
they could get infected even after vaccination and can spread infection 
too, then ideally, they should have understood that quarantine would 
be essential to some extent even after vaccination but only 43 % of 
HCWs felt so. This indicates that even HCWs had confused ideas about 
quarantine basics.
Vaccine acceptance
Vaccine rollout in India was done when COVID-19 cases and deaths were 
on declining trend. However, majority (49.19%) of study participants 
said that vaccine is required irrespective of present COVID-19 scenario, 
which was a good sign considering the second wave impacting the other 
countries during this time. Although only 20% of study participants had 
satisfactory awareness level, the voluntary acceptance rate for vaccine 
was very high (94.67%). Such a high acceptance level was very good 
and would influence general population also. The low awareness level 
about vaccine is probably because of vaccination rollout for HCWs was 
quick and in-depth awareness about vaccine details was low initially 
as detailed research findings were not yet out about vaccine. We could 
not find any study in this area, which was immediately carried out on 
vaccine rollout to assess the acceptance in India, as the authors were 
quick to carry out this study to see any hesitancy among HCWs so 
that any need to increase actions in terms of information education 
and communications (IEC) activities be found out at the earliest. 
Our study emphasizes the need for regular update of knowledge on 
vaccinations among HCWs, although it is a novel vaccine but true in-
depth information about vaccine must be disseminated among HCWs 
and general populace at the earliest, before any hesitancy is developed 
among them against vaccine.
Poor awareness score was seen among 83.19% of paramedic and 
61.90% of nursing staff then compared to medical officers, warranting 
specific IEC, and regular update to them about all aspects of COVID-19 
as the association between designated HCWs and awareness score was 
statistically significant. Poor awareness level was also seen among 80% 
of HCWs who did not have COVID-19 positivity earlier as compared 
to 68% of those who had prior COVID-19 positivity. The association 
between prior COVID-19 positivity status and awareness score was 
statistically significant. This indicates that HCWs who were COVID 
positive earlier were showing more interest on gathering information 
about vaccine than compared to COVID-negative HCWs. Thus, these 
HCWs should be targeted more.
The study carried out by Al-Qerem and Jarab [12] in Middle Eastern 
population, showed very low intend (36.8%) for vaccine even when 
Table 3: Acceptance of COVID-19 vaccine among study 
participants
Variables Frequency Percent




Acceptance for vaccine voluntarily even if available on payment
Can’t tell, depends on cost 53 7.85
No 440 65.19
Yes 182 26.96
COVID-19: Coronavirus disease 2019
Table 4: Graded response of study participants on COVID-19 vaccine (On a visual analog scale ranging from 0 [minimum] to 5 
[maximum])
Variables Grading (%)
0 1 2 3 4 5
Vaccine effectiveness – – – 116 (17.19) 208 (30.81) 351 (52.00)
Requirement of vaccine based on current scenario – – – – 227 (33.63) 448 (66.37)
Vaccine side effects 366 (54.22) 174 (25.78) 135 (20.00) – – –
Requirement of taking vaccine by person who is 
previously COVID positive
31 (4.59) 176 (26.07) 332 (49.19) 136 (20.15) – –
COVID-19: Coronavirus disease 2019
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are highly justifiable as countries are fast tracking the manufacturing 
of vaccine with results based on clinical trials. The most important is 
the information warfare. Lots of vaccine misinformation do persists in 
social media as fake messages. Such fake messages should be identified 
and removed and only realistic true information to be made available to 
all, through social media and IEC activities to be carried out on regular 
basis which would improve the vaccine acceptance and remove the 
hesitancy. Various studies have suggested approaches to tackle vaccine 
hesitancy [20,21]. For example, Arede et al. suggested that main issues 
concerning hesitancy were vaccine concerns, plus personal and societal 
factors. The authors suggested best approaches including long-term 
approach that involves targeting different age groups on vaccine basics 
and nullifying the floating false messages. The general population along 
with HCWs should be made to understand that approved vaccines are 
safe and go through thorough evaluations, risk and benefit assessment 
checks. Herd immunity can eliminate diseases in which vaccination 
plays an important role as evident by various communicable diseases 
[21].
As per the latest report on February 24, 2021, of Johns Hopkins 
Bloomberg School of Public Health, in a survey carried out from 23 
countries, there was overall drop in COVID-19 vaccine acceptance 
with increased acceptance in nine countries [22]. Since vaccination is 
critical part to end COVID-19 pandemic, all measures to be taken on 
regular basis to increase vaccine acceptance rate. This needs a strong 
communicating policy in this era of misinformation.
CONCLUSION
The decision of vaccine prioritization to HCWs and FLWs will boost 
the morale and spirit of warriors high in future. This study was a 
preliminary attempt to check any vaccine hesitancy factors among 
HCWs and act accordingly. Although almost all had volunteered 
for vaccine, the knowledge about vaccine was poor in majority of 
HCWs as the time period was recent to vaccine rollout and detailed 
research findings were not yet out about vaccine. All measures to be 
taken including intensive IEC activities targeting HCWs and general 
population on regular basis to upgrade the knowledge on vaccine 
issues. A strong communicating policy in an era of misinformation 
is highly recommended as social media plays an important role in 
spreading true as well as false messages jeopardizing the entire gains of 
successful vaccination and attainment of herd immunity. HCWs to act as 
role-model for patients as well as general public to increase the vaccine 
acceptance rate among them.
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the cases in their region increased rapidly during that time compared 
to our study where vaccine acceptance was very high even when cases 
and death rates were low, implying our HCWs had better acceptance 
than other. The acceptance level of our HCWs was much higher when 
compared to global survey that included participants from 19 countries 
(71%) [13] and studies carried out in Saudi Arabia (64%) [14], France 
(76%) [15], China (91%) [16], Ecuador (97%) [17], and the United 
States (57%) [18].
In our study, although 94.67% had vaccine acceptance voluntarily, 
80% of males had poor awareness scores than compared to female 
(70.42%) and the association between gender and awareness scores 
was statistically significant (p=0.02). This is contrary to the findings of 
Al-Qerem and Jarab [12] in Middle Eastern population along with other 
studies carried out in Europe [19], China [16], and France [15] were in 
females had less intent for vaccination. Studies also showed predictors 
age [15] and income [15,19] as predictors for low intent for vaccination. 
Al-Qerem and Jarab [12] showed being female, education up to 
postgraduate degree and being married were predictors for vaccination 
intention while in our study, designation, gender, and prior COVID-19 
positivity were significant predictors for COVID-19 vaccine awareness 
scores. While all these above studies were on mixed population (non-
HCWs and HCWs), our study was mainly on HCWs.
Vaccine acceptance barriers
In this study, although there were no vaccine acceptance barriers as 
almost all volunteered for vaccine, 80% of study participants had poor 
awareness scores which was of high concern. The awareness level as 
well as understanding the concepts of vaccination, COVID-19 protocols 
and related mechanism of action are very important for all HCWs as 
they play a lead role in implementing and making general population 
as well as patients aware and motivate them for vaccination. All HCWs 
need to have adequate knowledge on vaccine efficacy and side effects. In 
our study, graded response of study participants on COVID-19 vaccine 
(on a visual analog scale ranging from 0 [minimum] to 5 [maximum]) 
was assessed, as shown in Table 4. About 52.00% graded five with 
respect to vaccine effectiveness, 66.37% graded five for requirement 
of vaccine based on current scenario, 54.22% graded zero for vaccine 
side effects while 49% graded two for requirement of taking vaccine 
by person who is previously COVID positive. Concerns of vaccine side 
effects and efficacy are across the world. Al-Qerem and Jarab [12] 
also showed, vaccine concerns were the main reason for hesitancy or 
refusal among study participants. Even in studies carried out at China 
[16], Europe [16], and the United states [18], study participants had 
concerns about vaccine safety and efficacy. The concerns about vaccine 
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